Yüklüyor......
Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
Hypercholesterolemia and hypertension are among the most important risk factors for cardiovascular (CV) disease. They are also important contributors to metabolic diseases including diabetes that further increase CV risk. Updated guidelines emphasize targeted reduction of overall CV risks but do not...
Kaydedildi:
| Yayımlandı: | Korean Circ J |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Society of Cardiology
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5537141/ https://ncbi.nlm.nih.gov/pubmed/28765731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2016.0406 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|